EnVVeno Medical Corporation
NVNO
Rank in Stocks
#30632
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Share Price
$6.85
Last synced: 2026-11-09
Market Cap
$4.76M
Change (1 day)
1.78%
Change (1 year)
-72.20%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade EnVVeno Medical Corporation (NVNO)
Category
Healthcare
EPS for EnVVeno Medical Corporation (NVNO)
EPS as of September 2026 TTM: $-244.62
According to EnVVeno Medical Corporation's latest financial reports, its current EPS (TTM) is $-244.62. At the end of 2025 the company had an EPS of $-33.06, an increase over its 2024 EPS of $-1.56K.
EPS history for EnVVeno Medical Corporation from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-244.62 | 639.93% |
| 2025 | $-33.06 | -97.87% |
| 2024 | $-1.56K | -33.51% |
| 2023 | $-2.34K | -13.18% |
| 2022 | $-2.70K | 15.79% |
| 2021 | $-2.33K | -74.80% |
| 2020 | $-9.24K | -37.69% |
| 2019 | $-14.82K | -72.29% |
| 2018 | $-53.50K | 105.22% |
| 2017 | $-26.07K | 150.35% |
| 2016 | $-10.41K | 132.24% |
| 2015 | $-4.48K | -13.68% |
| 2014 | $-5.19K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -101.10% |
US
|
|
| $4.09 | -101.67% |
IE
|
|
| $9.45 | -103.86% |
US
|
|
| $2.37 | -100.97% |
US
|
|
| $1.77 | -100.72% |
US
|
Questions about EnVVeno Medical Corporation's earnings per share (EPS)
What is EnVVeno Medical Corporation's earnings per share (EPS)?
EnVVeno Medical Corporation's earnings per share (EPS) over the last twelve months is $-244.62, as of Sep 2026.
What was EnVVeno Medical Corporation's earnings per share (EPS) in 2025?
In 2025, EnVVeno Medical Corporation's earnings per share (EPS) was $-33.06, compared with $-1.56K in 2024.
How has EnVVeno Medical Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, EnVVeno Medical Corporation's earnings per share (EPS) was highest in 2025 ($-33.06) and lowest in 2020 ($-9.24K).
How does EnVVeno Medical Corporation's earnings per share (EPS) compare with similar companies?
EnVVeno Medical Corporation's earnings per share (EPS) ($-244.62) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.